{"organizations": [], "uuid": "24a203587accfa83b02e3eb916d2d6be1bc54975", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teligent-inc-announces-fda-approva/brief-teligent-inc-announces-fda-approval-of-halobetasol-propionate-ointment-0-05-idUSASC09T5O", "country": "US", "domain_rank": 408, "title": "BRIEF-Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05%", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-21T14:45:00.000+02:00", "replies_count": 0, "uuid": "24a203587accfa83b02e3eb916d2d6be1bc54975"}, "author": "", "url": "https://www.reuters.com/article/brief-teligent-inc-announces-fda-approva/brief-teligent-inc-announces-fda-approval-of-halobetasol-propionate-ointment-0-05-idUSASC09T5O", "ord_in_thread": 0, "title": "BRIEF-Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05%", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "inc", "sentiment": "negative"}, {"name": "teligent inc", "sentiment": "none"}, {"name": "teligent inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 46 PM / Updated 11 minutes ago BRIEF-Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05% Reuters Staff March 21 (Reuters) - Teligent Inc: * TELIGENT, INC. ANNOUNCES FDA APPROVAL OF HALOBETASOL PROPIONATE OINTMENT, 0.05% * TELIGENT INC - EXPECT TO LAUNCH HALOBETASOL PROPIONATE OINTMENT, 0.05% IN Q2 OF 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-21T14:45:00.000+02:00", "crawled": "2018-03-21T14:58:57.012+02:00", "highlightTitle": ""}